Tuesday, 8 June 2021
Ocugen pays $15 mn upfront to Bharat Biotech for Covaxin rights in Canada
Similar to the US arrangement, Ocugen will retain 45 per cent of the profit from sales of Covaxin in Canada.
from The Hindu - Business
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment